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geneous immunoassay technology that permits determination of Resistance/epidemiology 11 
multiple analytes in serum, pllasma or whole blood, differentiating 
monomeric latex particles from latex aggregates and cells on the 
basis of the light scatter properties. EIA test was considered the refer- 
ence method. Additionally, we used latex agglutination tests controlled by encouraging quinolone usage 
(CMVEKSUScan, Becton Dickinson, Pastorex toxo and rubella, 
Sanofi Diagnostics Pasteur) to evaluate disagreement results. 
lp837) An outbreak of enterococcal infection 
A.E Fraise', S. Bass', B. Cunningham', M.J. Gill', K. Wise', P.M 
Hawkey'. 'Department of Patholqx City Hospital ,VHS Tnrst, Results: The results are showed in the tables below: 
Sensibility(%) Specificity(%) Agreement(%) 
CMV 96.96 83.87 94.47 
Rubella I on 91.66 94.22 
Toxoplsrma 97.36 94.59 95.40 
Conclusions: COPALIS is a sensitive, specific and acceptable 
method for the detection of Ah against CMV, rubella and toxo- 
plasma. 
lp8361 Comparison of serologic tests and bone 
marrow aspiration for the diagnosis of visceral 
leishmaniasis 
E. Cani', M.T. Schick', G. Kuli', 13. Kraja', N. Xhyhed.  
'Departmmt qffnfirrobiolo,gx Inrtiture of Public Health, u/HO/HM, 
University Hospital Center, Tirana, Albania 
Objectives: To establish the method of choice for the diagnosis of 
visceral leithmaniasis in Albania. 
Methods: Sera from 115 p e n t s  hospitalized at the Universiry 
Hospital Center Tirana betwemen 1995 and 1997 were analyzed for 
IgC antibodies against Leisltrnavia infanturn by direct agglutination and 
a new, not yet commercially available, ELISA test (Laboratoires 
Bordier, Lausanne, Switzerland). The results were compared to thote 
from bone marrow aspiration. The ELISA test was also performed 
on 44 sera from healthy blood donors. 
Results: In total, 112 samples were positive for IgG antibodies 
both with direct agglutination and with ELISA. Bone marrow aspi- 
ration resulted in 109 cases confirmed by microscopy afier staining 
with GIEMSA; i.e. 3 patients with a positive serology from both tests 
used were not picked up by bone marrow aspiration. Another 3 
patients were clinically suspected cases, but neither one of the sero- 
logic tests nor bone marrow aspiration could confirm the diagnosis. 
All 44 samples from healthy blood donors analyzed by ELISA were 
negative. 
Conclusions: The two serologic methods gave 100% concordant 
rcsults. In 3% of the patients, bone marrow aspiration failed to iden- 
tify the cases. In our study, the specificity of the new ELISA test was 
100%. Since the serologic tests used in our study were more sensitive 
than bone marrow aspiration and serology is clearly far less invasive, 
we reconimend the use of either direct agglutination or ELISA, the 
choice between the two depending on the availability and the costs 
involved. 
Birrniny&m, ZUrriversity o j  Lefds, b e d s ,  U K  
Cephalosporins are known to be an important risk factor for ente- 
rococcal infection. During a period when ceftazidiiiie (CAZ) use on 
a 7-bed intensive care unit (ITU) averaged 22.4 defined daily dore5 
(DDDs) per month, we identified an outbreak of enterococcal infec- 
tion. There was a greater than 10-fold increase in the rate of isola- 
tion ofinfecting enterococci over a 15-month period (5.5 isolates per 
1000 bed days at the beginning compared with 66 isolates per 1000 
bed days at the end). Microbiological saiiipling did not alter over this 
period and isolates were associated with clinical evidence of infec- 
tion. The increase was mainly due to E. fecalis (69 isolates), which 
repi-esented 1%) of all Gram-positive isolates in the first 3 inoiiths but 
41% in the last 3 months (P<0.001). Pulsed-field gel electrophore- 
sis of Stria1 chromosome digests showed two distinguishable strains of 
E.fecolis with some associated cross-infection. In addition there were 
infections due to E.faecinrn (9 isolates), E. dnronr (2 isolates) and other 
species of enterococci (5 isolates) . Following a change from 
cephalosporin use to ciprofloxacin use, the prevalence of enterococ- 
cal infection was monitored for a further 12 months, during which 
time there were no changes in microbiological or infection control 
procedures. Ceftazidime use decreased from 22.4 to 5.1 DlXIs 
per month and quinolone usage increased from 16.9 to 32 DDDs per 
month. Enterococcal isolates decreased from 92 to 10.2 isolatrs per 
1000 bed days in the first and last quarters ofquinolone use. Although 
quinolones have poor activity against enterococci, they niay not 
disturb the bowel flora as much as cephalosporins. Replacenient of 
cephalosporins with quinolones may assist in the control of outbreaks 
of enterococci. 
lp8381 Antibiotic resistance in clinical isolates of 
enterococci from North-Rhine Westphalia and 
analysis of clonal relatedness of glycopeptide- 
resistant strains from German hospitals 
I .  Klare', G. Werner', G. Conrads', JJ Schlaeger', K. Lutticken', 
W. Witte', R.K. Reinert'. 'Robert Kocli Institute, Wm<qerodt., 
ZNational Referetzre Center.fir Streptococci, Urlivrrsity Hospital Aatlierz, 
Germany 
Objectives: Antibiotic i-esistance rates and genotyping of eiitt'ro- 
cocci. 
Methods: Agar dilution teyt, macrorestriction analysis, platniid 
isolation and restriction analysis, hybridization. 
Results: In 1997, clinical isolates of enterococci (n=730; one 
strain per patient) originating from 22 microbiological laboratories in 
North-Rhine Westphalia (Germany) were analyzed. These strains 
(n/%j were isolated froni: urogenital tract (312/42.7), wounds 
(165/23.0), respiratory tract (79/10.8), blood (68/9.3), catheter or 
drainage (39/5.4), CNS (4/0.6), other sources (60/8.2j. They 
included the enterococcal species E. feralir (648/88.9), E. ,faerilrnz 
(72/9.8), E. hirae, E .  aviitm, E.  casse@ovics (each ofthose: 3/0.4), and 
E. durans (1/0.1 j .  The following percentages of antibiotic resistance 
(all enterococci/E. fe ra l i s /€ .  faecirrnt) were determined ampicillin 
(7.4/0.9/66.7), high-level gentaiiiicin ( I  5.0/ 14.81 18. l ) ,  high-level 
streptomycin (28.1 /25.6/52.8), ciprofloxacin (37.9/ 33.8/81 .Y), vaiico- 
mycin (1.5/0.5/11.1), teicoplanin (1.5/0.5/11.1). All glycopeptide- 
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resistant enterococci (GRE) were of the vanA genotype. Five GRE 
isolates originating from five patients of one hospital in North-Rhine 
Westphalia showed identical Smal  and Apal macrorestriction patterns 
and additionally to GRE isolates from outbreaks of infections in 
hospitalized patients from Bavaria and Hesse. These data suggested 
an intra- and inter-hospital spread. However, restriction analysis and 
hybridizations indicated a localization of vanA on different plasmids 
in these five isolates. 
Conclusions: GRE seem not to be a major problem in this part 
of Germany Besides macrorestriction analysis, further molecular 
methods can be useful when genotyping enterococci. 
)p839) Clonal spread of high-level aminoglycoside 
resistance in enterococci 
N. van den Braak, A. van Belkum, W.H.E Goessens, D. Kreft, 
H.A. Verbrugh, H.Ph. Endtz. Medical Microbiology and Infectious 
Diseases, Erasmu5 University Medical Center, Rotterdam, The  
Netherlands 
Introduction: Although enterococci belong to the normal flora of 
the human gastrointestinal tract they sometimes cause serious infec- 
tions, including bactereniia and endocarditis. The treatment of these 
infections is often based on a combination therapy of aminoglyco- 
sides and beta-lactam antibiotics. This combination therapy is syner- 
gistic and bactericidal as long as the strain is not high-level resistant 
to the aminoglycoside.The increasing prevalence of high-level 
gentamicin-resistant enterococci (HLGRE) in hospitals worldwide is 
of great concern. 
Objectives: To study the prevalence and clonality of HLGRE in 
a Dutch university hospital. 
Materials: 238 enterococci isolated between June 1991 and June 
1997 from patients with positive blood cultures. 
Methods: Vitek 30 wells GPS-TA, Etest, pulsed-field gel elec- 
trophoresis (PFGE) and PCR. 
Results: 57/238 entrococcal strains were high-level gentamicin 
resistant. The genes encoding aminoglycoside-modifying enzymes in 
enterococci were determined by PCR. All strains had the gene 
aac/aph. 16/57 (28%) also had the aphA3 gene and 1/57 (2%) 
contained the aadC gene. DNAs of these 57 isolates were analyzed 
by PFGE. Nineteen different genotypes were identified. Two geno- 
types were more prevalent (A (12157) and B (23/57) over the years. 
Conclusions: From 1991 to 1997 the incidence of HLGRE 
increased from 14% to 31% due to the spread of two predominant 
HLGRE types. The incidence of strains with a unique PFGE pattern 
increased from 4% to 16%. Also, nosocomial spread ofclonally related 
strains contributes to the increasing occurrence of HLGRE. 
LP8401 High frequency of E. faecium in farmers' gut 
flora 
T. Sorensen, R.L. Poulsen, N. Frimodt-Mder, F. Espersen. 
Research and Development, Statens Serum Institute, Copenhagen, 
Denmark 
Objectives: To investigate the carriage rate of enterococci using the 
rectal swab method and the distribution of different enterococcal 
species in the commensal gut flora in different groups exposed to 
varying amounts of antimicrobials. 
Materials and methods: Rectal swabs were obtained from 288 
persons: 61 pig producers, 58 abattoir workers, 57 nurses, working 
mainly in hospital wards with a high use of antimicrobials, and 112 
army recruits. After transport in Stuarts medium the swab was 
whirled in 1 mL of serum broth. 200 pL was plated on bile esculine 
azide agar, and after 24 h of incubation a colony was selected at 
random for further identification. 55 pig pen samples (every sample 
made up of five fecal samples from five pens on one farm) were 
treated in a similar way 
Results: From the participating groups, enterococci were more 
frequently isolated from groups exposed to an increasing antimicro- 
bial selection pressure; 42% (47/112) among army recruits versus 74% 
(45/61) of pig producers (pO.001). In pig producers (and in their 
pig), Enferococcus faecium was more often the randomly selected 
species, i.e. 23% (14/61) in pig producers versus 6% (7/112) in army 
recruits (p=0.005). 
Conclusions: Using this method, pig producers had a higher 
carriage rate of enterococci and a higher fraction of Enferococcus 
faecium in their feces. This could be due to a massive exposure of resis- 
tant enterococci and a high level of antimicrobial agents in their envi- 
ronment. 
Ip8411 Quinupristin/dalfopristin-resistant enterococci 
in poultry meat samples from Germany 
G. Werner, I. Klare, W. Witte. Robert Koch Institute, Wernigerode, 
Germany 
Objectives: Investigation of poultry meat samples for quin- 
upristin/dalfopristin (Q/D)-resistant enterococci. 
Methods: MIC testing, macrorestriction analysis by pulsed-field 
gel electrophoresis (PFGE), PCR, filter mating. 
Results: Twenty-five poultry meat samples from different 
German producers were tested for colonization with QD-resistant 
enterococci (QDRE). Strains were isolated from the thawing liquid 
ofpoultry carcasses on Enterococcosel-agar with Q / D  8 mg/mL The 
resistant isolates were further tested on Enterococcosel-agar with 8 
mg/mL mupirocin for separation from inherently Q/D-resistant E. 
fecalis. Q D R E  (E. faecinm, E. h i m  and E. durans) have been isolated 
in 6 of 24 poultry samples. After pre-enrichment in brain-heart infu- 
sion broth (without antibiotics, overnight, 37°C) another 5 of the 
remaining 18 samples were positive for QDRE (E. faecium and E. 
durans). pQDRE from the 11 poultry samples exhibited different 
macrorestriction patterns in PFGE, as did QDRE from human 
sources as controls. Amplification by P C R  indicated the existence of 
the satA gene (encodes for Q / D  resistance in enterococci) in isolates 
from 6 of the 11 poultry samples. Four of 10 isolates (2 satA+, 2 satA- 
) transferred their Q/D resistance determinant in filter mating into 
an E. faecium recipient. 
Conclusions: QDRE occur in poultry meat. As streptogramins 
have not been used until now in human chemotherapy, selection by 
the use of virginiamycin as feed additive is rather likely. 
lp842] High prevalence of resistance to clindamycin 
ICC) among Bacteroides fragilis group in an 
area of Madrid, Spain 
J. Oteo Iglesias, B. Aracil, J.I. Aks, J.L. G6mez-Garcks. Servicio de 
Microbiolop, Hospital de Mdstoles, Madrid, Spain 
Objectives: To study the antimicrobial susceptibility of 100 strains 
of the B.&ufilis group isolated in 1998 to CC, 100 strains of the B. 
jagi l is  group were isolated from fecal samples of healthy people. 
Minimun and to five other antianaerobic agents: metronidazole 
(MDZ), meropenem (MPM), cefoxitin (CFOX), amoxycillin/clavu- 
lanic acid (A/C) and trovafloxacin (TR). 
Methods: Inhibitory concentrations were determined by the agar 
dilution method using Wilkins-Chalgren medium to six antianaero- 
bic agents. Cultures were incubated for 48 h at 35OC in an anaero- 
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bic atmosphere. Results were interpreted according the current crite- 
ria of NCCLS. 
Results: Results expressed in mg/L as follows: 
Range MICm hfIG S(%) I(%) R(%) 
MPM sO.12-4 0.25 1 100 0 0 
CC <0.5>256 4 256 49 2 49 
MDZ 50.25-0.5 50.25 0.5 100 0 0 
CFOX a->64 32 64 46 36 18 
A/C 51-16 i l  8 83 13 4 
TR 0.12-2 0.25 0.5 100 0 0 
Conclusions: (i) High prevalence of resistance to CC in the B. 
fra@lis group suggests that empirical treatment should not be used, 
although when infections due to these organism are sutpccted, this 
is a frequent practice in abdominal surgery. (ii) More than 50% of the 
strains were considered rerist.int or intermediate to CFOX. (iii) 
MPM, MDZ and T R  show excellent in vitro activity against the B. 
ja,qilis group. 
Ip843( In vitro susceptibility of anaerobic isolates in 
1997-98 
E. Chmelarovl, V Torsova, D. Chnielar. National Anaerobic Bacteria 
Reference Laboratury, Antibiutic Center, Regional Institute .f Hygiene, 
Ostraua, Czech Repuhlir 
The succeptibilities of anipicilliri/sulbactam (AMP/SUL), piperacillin/ 
tazobactani (PIP/TAZ), cefoxitin (CXT), meropenem, (MER), clin- 
damycin (CLI) and metronidazole (MTR) were tested. Minimum 
inhibitory concentrations (M[C) for 814 anaerobic strains were 
determined by a broth dilution method according to NCCLS recom- 
mendations. 
The production of beta-lactamate was determined by using nitro- 
cefin disks. Anaerobic strains were isolated from different abscesses, 
intra-abdominal infections, pelvic inflanimatory diseases and necro- 
tizing infections ofsoft tissues. 'The table shows MlCsrl (mg/L) values 
for most common organisms. 
CLOSTRIDiUM 
Conclusions: The results show very good activity for the tested 
antibiotics. The lowest MICW was determined for nieropeneni. 
Clinical laboratories have to dtternline reliable susceptibility testing 
o f  anaerobes for optimal antibiotic therapy of severe anaerobic infec- 
tions. Monitoring of anaerobe susceptibility patterns is needed for 
individual hospitals and regional national centers. 
lp8441 Detection of irnipenem-resistant and 
rnetronidazole-resistant Bacteroides fragilis 
group strains in fecal samples 
M. Hedberg', H. Fang', C. Edlund'. 'Deparftnrrit qflmmrinolry),, 
Mirrobiolofy, Patholqy mid I&tioir.s Diceusex, H d d i q c  Urzivrrcity 
Hospital, Karoliitska Institutrt, 
Stockholm, Swedeti 
Objectives: To detect the resistance genes (rcrA and witn) coding for 
itnipenem and metronidazole resistance in the Bacfcr~~idcs.fraei/is group 
straiiis. 
Methods: Fecal samples froin 729 diarrheal patients 2nd 196 
healthy controls were collected at Huddiiige University Hospit,il in 
1997. The fecal samples were inoculated in prereduccd peptonr yea\t 
glucoce broth (PYG) containing kanamycin (0.8 nig/iiiL) and incu- 
bated at 37OC for 48 h. After incubation the samples were: (1)  
cultured on blood-kanartiycin-vanc~rtiycin plates with iniipencm 
and nietronidazole disks (modified disk diffusion method)-DNA 
was extracted froni pure bacterial colonies resistant to imipeneni or 
metronidazole or both drugs, for subsequent PCR (purePCR); (2) 
DNA was directly extracted from the PYG, for subtequent PCR 
(dirPCR); (3) DNA was extracted from the PYG by use ofimniuno- 
magnetic bead separation for subsequent PCR (imsPCR). Specific 
primers for amplification of the ccrA and nim genes were used 
together with different concentrations o f  the ternplatc DNA. 
Results: Two iniipeneni-resistant B. .fra<qilis strains (B. j i q i l i s  003 
and 161 9) and one metronidazole-resistant B. j q i h  strain (B .  j q i l i r  
1619) and five other metronidazole-recistant strains (B. distosoiiis 7x2, 
3667, B. thctaiotaomirron 2877, B. nrr$wmis 2935 arid B .  vr i~~af i t s  2985) 
were detected by the modified disk diffusion method. The rcrA gene 
was detected by dirPCK, inisPCK and purePCR in B. jkacqilis 603 
and 1619. 
Conclusions: Resistance genes can be detected from fecal 
samples without pure bacterial isolates. This niay be useful in epi- 
demiologic Ttudies of distribution of resistance genes in the fecal 
microflora. 
L hivercity (Mqcc of South Srocklroirn, 
(p8451 Serotype patterns of invasive Streptococcus 
pneumoniae in the Slovak Republic 
I. Trupl', H. Hupkovi2, 0. B a l i d ,  I .  Stankovic', Pneumococcus 
Study Group. 'Department cf Clinical Microbiology, Natiorzal Caiicer 
Instirim, 'Department of Clinical Microbioloqy, St Cyril nwd Mrthod 
Hocpital, 'Hospital of Infectious Diccascs atid Grcyuphic M r d i h w ,  
Bratislava, Slovak Republic 
Objectives: S. pneumorriae is a significant cause of invasive bacterial 
diseases. Resistant strains have been reported in the Slovak Republic 
during the last few years (Chemotherapy 1997; 43: 316-322). The 
aim of this study was to determine the capsular serogroups ofpneu- 
mococci and levels of resistance to penicillin and other drugs. 
Methods: A total of 11 1 clinical isolater froin sterile body fluid? 
were examined between October and November 2998. All strains 
were sent to the central laboratory of the study for susceptibility test- 
ing and serotyping. Pneuniococci were serogrouped and serotyped 
using Quellung reaction with antisera froin the Statrns Serum lnstitut 
Copenhagen. I-pg oxacillin disk was used to Ycreen for resistance to 
penicillin. MICs were determined according to NCCLS. 
Results: 11 1 isolates taken froni CSF (32.5%), blood (42.3%), 
pleural fluid (5.4%), lung (3.693, heart (1.8%) and other normally 
tterile fluids (14.4%) isolated from patients with meningitis (38'%1), 
sepsis (43.2%). pneumonia (9.9%) or other clinical diagnosis (X.9'X)) 
were analyzed. The strain3 of pneuniococci differed in 23 different 
serogroups. The most prevalent types were 19A, 23F, IOF, 14, 20, SV, 
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9A, bA, 4, 8 and 7E 15 (15.5%) among the 11 1 strains had high-level 
resistance and 19 (19.6%) had low-level resistance to penicillin. 10 
strains (10.3%) had high resistance, and 17 (17.5%) had low resistance 
to ceftriaxone. 
Conclusions: Continuous survedlance of S. pneumoniae should be 
maintained to obtain data on pneumococcal types, to monitor 
changes in type distribution and to assess the incidence and spread of 
drug-resistant pneumococcal strains. This study was supported by the 
Grant Agency, Ministry of Health of the Slovak Republic. 
lp8461 Persistence of streptococcus pneumoniae in a 
patient with cystic fibrosis 
S. Wagner’, A. Koni? , H. Mauch’, R. Hakenbeck3. ’Ltmngenklinik 
Heekeshorn, Berlin, ’Max-Planck Institutfiir Molekulare Cenetik. 
Berlin, ’University of Kaiserslautern, Kaiserslautern, Germany 
Our objective was to analyze the gene pool accessible to S. pneumo- 
wiae. 
S. pneumoniae resistant to B-lactam antibiotics were obtained from 
the Berlin Hospital of Heckeshom between 1992 and 1995. Nine of 
these strains were isolated from one patient, and all nine were of 
serotype 23F and intermediately resistant to penicillin. Analysis of 
penicillin-binding protein (PBP) profiles strongly suggested that they 
are members of one clone. DNA sequencing of the pbp2x genes after 
PCR amplification confirmed this: the three pbp2x  genes analyzed 
were identical to each other and to a clone that had been isolated in 
Hungary and the former East Germany (Reichmann et al. J Med 
Microbiol 1995; 43: 377-85). Comparison to the genes obtained 
from four oral streptococci of the same patient showed the presence 
of at least another four different pbp2x homologs. No evidence was 
obtained for in vivo pbpP2.x gene transfer. However, the pbp2x  vari- 
a n t ~  could be transformed into S. pneurnoniae under laboratory condi- 
tions, showing that a gene pool accessible to the pneumococcus was 
present in the host. 
lp8471 No evidence for Staphylococcus aureus 
heterogeneously resistant to vancomycin at 
Freiburg University Hospital, Germany 
T. Schulin’, A. Serr’, D. Hartun$, D. Jonas2, K. Pelz’. ‘Instituffiir 
Milerobiologie und Hygiene, ZInstiturfiir Umweltmedizin und 
Krankenhaushygiene. Albert-Ludwip- Universitiit Freiburg, Freibutg, 
Germany 
Stapylococrus uurew (SA) is a major pathogen in community- 
acquired as well as in nosocomial infections. Therapy may be difi- 
cult in cases of infection with methicillin-resistant (MR) strains, and 
vancomycin is the therapy of choice for those strains. Lately, MRSA 
with reduced susceptibility to glycopeptides and subsequent treat- 
ment failures have been described in Japan and the US (MIC 8 g/L). 
In Germany, heterogeneously resistant strains have been detected in 
MRSA outbreaks, but no treatment failure was observed. The aim 
of the present study was to screen local MRSA isolates for decreased 
susceptibility to vancomycin. 50 clinical strains h m  1992 to 1998 
were screened on BHI agar with 4 g/L vancomycin. The inoculum 
was 10h/spot. After 24 h and 48 h of incubation at 37OC the plates 
were read for single colonies or confluent growth, which would 
represent increased MICs to vancomycin. We could not detect any 
MRSA that exhibited reduced susceptibility to vancomycin at our 
institution up to this time. 
)p848) Phylogenetic relatedness between Swiss 
MRSA strains and European epidemic clones 
D.S. Blanc, A.-L. Banuls, P.M. Hauser, C. Ruef, D. Pittet, A. 
Widmer, C. Petignat, S. Harbarth, EH. Kayser, R. Frei, R. 
Auckenthaler, J. Bille, P. Moreillon, P. Francioli, M. Tibayrenc. 
Division Autonome de Mbdecine Prdventive Hospitalidre, Centre 
Hospitalier Universitaire Vaudois, Lauranne, Switzerland 
Objectives: To study the phylogenetic relatedness of methiciuin- 
resistant Staphylococcus aureus (MRSA) strains from Switzerland with 
European epidemic clones. 
Methods: Random amplification polymorphism DNA (RAPD) 
typing, using 12 primers, of 18 European epidemic clones (39 
strains), 45 strains isolated in Switzerland in 1996-97 and 15 refer- 
ence strains from 5 other Staphylococcus species. Phylogenetic analysis 
of the data. 
Results: RAPD typing of the 99 strains enabled the recognition 
of 195 band positions. The dice coefficient of similarity and the 
unweighted pair group method of analysis were used to construct a 
dendrogram. The results showed that the minimum similarity 
between MRSA strains was 0.48, whereas the maximum similarity 
between the 6 Staphylococcus species was 0.15, indicating that the 
method permits phylogenetic analysis. The 18 European epidemic 
clones were distributed into 6 phylogenetic lineages with a minimum 
similarity of 0.85. All the 45 Swiss strains, except 3, were clustered 
into these 6 phylogenetic lineages. Epidemiologic data of the Swiss 
strains showed that most of them were isolated from sporadic cases. 
One lineage was found to be epidemic in other European countries 
as well as in Switzerland. 
Conclusions: The 18 MRSA clones reported to be epidemic in 
European countries during the 1990s. 
lp8491 MRSA clones isolated from inpatients at the 
University Hospital of Patras, Greece 
1. Spiliopoulou’.2, M. Aires de Sousa2, C. Bartzavali’, G.O. 
Dimitracopoulos‘ , I. Santos Sanche~’.~, H. de Lenca~t re~~”~.  
‘Department of Microbiology, School of Medicine, University of Patras, 
Greece; ’Inrtituto de Tecnologia Quimica e Bioldgica, Universidade Nova 
de Lisboa, Oeiras, Portupl; ’Faruldade de Ciincias e Tecnologia, 
Universidade Nova de Lisboa, Monte da Caparica, Portugal; ‘The 
Rockefeller University, New York, USA 
Objectives: In order to determine the genetic relatedness of methi- 
cillin-resistant Staphylococcus aureus strains (MRSA) isolated from 
inpatients in a 750-bed university hospital in Patras, Greece, we have 
analyzed two collections of strains recovered during the first 
trimesters of 1993 (group 1) and 1998 (group 2). 
Methods: Twenty-four multiresistant MRSA isolates (1 0 from 
group 1 and 14 from group 2) were studied. The molecular nieth- 
ods used for typing these strains were: (i) digestion ofDNA with Cld 
followed by non-radioactive hybridization with DNA probes: (a) the 
mecA and (b) the transposon Tn554; and (ii) pulsed-field gel elec- 
trophoresis (PFGE) of SmaI chromosomal digests. The clonal types 
were defined as rnecA::Tn554::PFGE types. 
Results: The prevalence of infections due to MRSA at the 
University Hospital of Patras has been 31.6% during the 5-year 
period. The majority of the strains (62.5%) corresponding to 8 
isolates from group 1 and 7 from group 2 belonged to clone 
VII’::NH::A, a subtype of the ClaI-mecA type VII, with no homol- 
ogy to Tn554. Three strains of group 2 belonged to the X : : K K : : B  
clone, showing a new Tn554 pattern. None of the group 1 isolates 
was classified into this type. The remaining 6 strains from both groups 
were classified into 4 different clones. PFGE patterns A and B are 
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unique and distinct from other PFGE profiles associated with other 
MRSA clones previously described, in a variety of countries. 
Conclusions: Although several clonal types were characterized in 
this collection of multiresistant MRSA, a major clone (VI1’::NH::A) 
seems to have been dominant in this hospital since 1993. In 1998 a 
distinct MRSA clone (X::KK::B) has emerged. 
Ip8501 MRSE clones associated with catheter-related 
infections at a university hospital 
I. Spiliopoulou‘.2, M. Aires de Sousa’, C. Bartzavali’, G.O. 
Dimitracopoulos’, I. Santos Sanches’.?, H. de Lencastre*~”‘. 
’Departmcnt ~~~Microbiology,  School of Medicine, University o f  Patras, 
Patras, Greece; zInrtituto de Zcntdogia Qnimica e Biolbfica, Universidade 
Nova de Lisboa, Oeiras, Portupi ;  ’Faculdade de CiQncias e Tecnoloxia, 
Universidade Nova de Lisboa, Monte da Caparica, Portufal; ‘The 
Rocktfeller University, New York, Nk: USA 
Objectives: Study of the clonality of methicillin-resistant Staphy- 
lococcus epidermidis (MRSE) strains isolated from clinical specimens of 
inpatients with bacteremia arid catheter-related infections, at the 
University Hospital of Patras, using molecular typing techniques. 
Methods: Seventy S. epidermidis strains were isolated from blood 
and catheter-tip cultures, from 62 inpatients. Thirty-six out of the 70 
isolates (51%) were methicillin resistant (MIC 4 pg/mL) and carried 
the me& gene (11 isolates from blood and 25 from catheter-tips). 
The iiiolecular methods used for typing the 36 strains were (a) diges- 
tion of DNAs with Clal followed by hybridization with the rnecA 
probe and (b) pulsed-field gel ,electrophoresis (PFGE) of SmaI chro- 
mosomal digests. The clonal types were defined as mecA::PFGE types. 
Results: Eight ClaI-mecA types were identified among the 36 
MRSE and designated as types 1-8; 12 isolates were type 1 (33.4%); 
9 were type 3 (25%); 6 were type 4 (16.7%); and 5 were type 2 
(13.9%); the remaining ClaI-mecA types were represented by single 
isolates only Twelve out of the 36 MRSE strains belonged to PFGE 
type B (33.4%) and 7 to type F (19.4%), while the other 17 strains 
showed 12 different PFGE patterns. The major clones were 1::B (9 
isolates, 25%), 3::F (3 isolates, 8.4%), 3::B and 4::F (2 isolates each or 
5.6%). 
Conclusions: The majority of the MRSE clinical strains isolated 
from patients with catheter-related infections belonged to two PFGE 
groups (I3 and F) and two major clonal types (1::B and 3::F). Clone 
1::B included isolates of both blood and catheter origin, whereas 
clone 3::F was only associated with catheter samples. 
Ip851( Typing of methicillin-resistant strains of S. 
haemolyticus found in hospital wards 
J. Chylak, W. Michalska, M. Drrws, R. Marciniak, M. Lange. 
Medical Microbiolqy, Marcinkow&; University of Medical Sciences, 
Poznau, Poland 
Objectives: This study characterizes 16 methicillin-resistant strains 
of S. haemolyticus colonizing drains of patients after intra-abdominal 
surgery and 9 strains of S. haemolyficur which were found in the hospi- 
tal environment, including hospital staff. 
Methods: Biotyping, antibiograms and fingerprinting were used 
to determine the relatedness oC 25 examined strains. Biotyping was 
performed with the ATB 32 Staph System (bioMCrieux). Antibiotic 
susceptibility testing with 11 antibiotics was performed using the disk 
diffusion method. Discrimination between strains was based on a 
single biochemical difference or on a single antibiotic resistance 
difference. Fingerprinting was pedormed with the use of one arbi- 
trary primer-5-GAGCTTCTGATGATGCTGCTG-3’. 
Results: 25 strains gave 15 biochemical profiles and 7 antibiogram 
patterns. Only 2 patient strains exhibited the same antibiograin and 
biochemical profiles as a few environmental strains. Fingerprinting 
allowed the 25 examined strains to be divided into three groups. 16 
strains of 25 showed the same pattern of PCK products. 13 strains of 
the 16 isolated from patients showed the same pattern of PCK prod- 
ucts as the strain isolated from the nasal anterior of a nurse. 
Conclusions: Only fingerprinting showed suacient discrimina- 
tory power to determine the relatedness of the isolated strains, and 
use of only one arbitrary primer is a cheap and easy method for 
presumptive determination of relatedness of iiiethicillin-resistant 
strains of S. haemolyticus. 
)p852) Mycoplasmasiureaplasmas: increase in 
resistance to tetracyclines, macrolides and 
quinolones from 1983 to 1998 
R. Krausse, S. Schubert, U. Ullmann. Departmerit cf Medical 
Microhiolo‘yy, University o f  K i d ,  Germany 
Objectives: To compare the susceptibilities of mycoplasinas and 
ureaplasmas, collected from 1983 to 1998, to various antimicrobials. 
Methods: The susceptibilities of 430 clinical isolates of Myro -  
plasma hominis (M.h., n=264), Ureaplasnta nrealytictrm (U.U., n= 142) 
and oral mycoplasmas (o.M., n=24) to the following 13 antimicro- 
bials were studied: doxycycline (DOX), ininoxyclin (MIN), tetracy- 
cline (TET), azithromycin (AZI), clarithromycin (CLA), erythromycin 
(ERY), josaniycin (JOS), roxithromycin (ROX), clindamycin (CLI), 
ciprofloxacin (CIP), fleroxacin (FLE), ofloxacin (OFL), and 
pefloxacin (PFX). Minimum inhibitory concentrations (MICs) 
(range 0.001-16 nig/L) were determined using an agar dilution 
method. 
Results: The M I C ~ , I / ~ ( ~  values and the percentage of resistant 
strains (MIC 8 nig/L) are shown in the table: 
Conclusions: M hominrs and U. nrealyticnm have btxonie more 
resistant to DOX, TET, CIP, OFL and EKY over the past decade. 
lp8531 The influence of azithromycin, clarithromycin 
and roxithromycin on the pharyngeal and 
intestinal flora 
V Schafer, P.M. Shah, T.A. Wichelhaus, K. Behrouzi, V. Brade. 
University Clinic, Institute o f  Medical Microbiolofy, FrarikjurtIM, 
Germany 
Objectives: To investigate the influence of azithromycin, clar- 
ithromycin and roxithromycin on the pharyngeal and intestinal flora. 
Methods: 13 inale healthy volunteers weru enrolled in this open 
cross-over study. An antibiotic-free period ofat least 28 days was kept 
between different antibiotic therapies. Intestinal and pharyngeal 
bacterial flora were documented quantitatively and yemi-quantita- 
tively respectively. 
Results: The results of the bacteriologic examination of the feces 
show a distinct effect of the macrolides on the intestinal flora. Under 
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therapy with azithromycin the number of Escherichia coli and other 
Enterohacteriaceae decreased below the detection limit and the phys- 
iologic flora is not restored until 3 weeks after therapy. With clar- 
ithromycin and roxithmmycin such a distinct alteration concerning 
reduction of Enterohacteriaceae could not he observed. Streptococcux 
spp. disappear under therapy with azithromycin, clarithromycin and 
roxithromycin but the physiologic flora is restored 4 days after termi- 
nation of medication. Lactobacteria and bifidobacteria show the same 
alteration with all three antibiotics. They diminish by 1000-fold and 
remain at this level during the observation period. Enteroroccur spp., 
Bacteroides spp. and Candida spp. are not influenced by the test drugs. 
The results of the bacteriologic examination of the pharyngeal wash 
do not show any significant alteration of the pharyngeal flora under 
therapy. A selection of Candida spp. was not observed. The physio- 
logic pharyngeal flora as well as transient and facultative pathogenic 
microorganisms were not influenced by any test drug during the 
observation period. 
Conclusions: In summary, clarithromycin and roxithromycin 
have no significant influence on the pharyngeal and the intestinal 
flora. Azithromycin, however, caused a distinct reduction, especially 
of the Enterobacteriaceae, in the intestine. 
[p8541 Anthrax infection as a model for use of 
molecular epidemiologic approaches in the 
struggle against infectious diseases 
Y.V. Mokhov, E.N. Belyaev. Federal Ceriter of State San-Epi Control 
o j  Ministry ojHeiealth cf Russian Federation, Moscow, Russia 
Anthrax infection through their biological properties doomed in 
future tense reviewed continue to manifest herself including and 
among the people. Therefore for such dangerous infection special 
importance acquire early diagnostics, timely notice of disease spread- 
ing and effective treatment of it. All these problems most effective as 
showed by us experimentally may be solved with use of molecular 
epidemiologic approaches. So, by the most effective method of the 
diagnostics of anthrax infection in the realization by Federal Center 
of control external of job quality of one from institutes of the san- 
epi control system through of testes encoded handout turned out a 
method of polymerase chain reaction (PCR). 
By the most epidemiologically and economically acceptable on 
suspicion of exposure to B. anthracis is the use of recombinant vaccine 
stram STI-AR which permits immunization in combination with 
antibiotic therapy carry out. Polyantibiotic resistant vaccine strain 
STI-AR created on the base of the vaccine strain STI-I B. anthracir 
with resistance to antibiotics of different classes (ampicillin, 
rifampicin, doxycyclin, chloramphenicol, macrolides and linco- 
mycin). Study of the protective properties of the new strain on 
animals against challenge with a virulent culture of B. anthracis using 
concurrent doxycycline therapy showed that doxycycline prevented 
the development of infection following exposure to the challenge 
whde not interfering with development of immunity in the group 
vaccinated with STI-AK. 
Appearance of any new factor of pathogenicity in a known viru- 
lent strain can he neutralized by means of cloning of this factor 
gene(s) in corresponding vaccine strain with following immuniza- 
tion. That proved by us by means of the expression of the cereolysin 
AB genes from B. cereus VKM-164 in B. anthracis strains: virulent H- 
7 (pXO1, pX02), vaccine STI-1 (pXOl), 221 (without its own plas- 
mids). Expression was achieved by cloning the genes in a high copy 
number plasmid. 
ml Antimicrobial resistance in BSI: I-year 
surveillance at local and European level 
M. Ghezzi, G. Raponi, C. Mancmi, Italian-Rome Center of 
ENARE-Sentry Study Group. Institute $Microbiology, La Sapienza 
University, Rome, Italy 
Objectives: To conipare the hequency and resistance patterns of 
bloodstream infection (BSI) isolates from an academic hospital in 
Rome with aggregate data from other 19 European centers partici- 
pating in the ENARE-Sentry project (coordinated by the Eijkman- 
Winkler Institute at the University Hospital Utrecht, The Netherlands). 
Methods: Data refer to strains longitudinally collected from April 
1997 until March 1998. Bacteria were collected only if representa- 
tive of BSI, a single strain during one infective episode. MICs were 
determined by the reference center using the broth microdilution 
method according to the NCCLS recommendations. Differences in 
the resistance to a given drug were considered if 10%. 
Results and conclusions: A total of 3044 strains were tested. 
109 were isolated in Rome: 74.4% were G+ and 25.6% G-. The 
European percentages were 51.1% and 48.9% respectively for G+ and 
G-. The Gf bacterium most frequently isolated was S .  aureus. The 
impact of MRSA in Rome was 68.6%, while the aggregate was 
21.9%. Among MRSA in Rome, a higher rate of resistance to 
gentamicin was noticed (99% versus 76.1%) together with enhanced 
resistance to third-generation cephalosporins, amoxycillin-clavu- 
lanate and cloramphenicol. I? aenrginosa was the G- rod most 
frequently isolated at the center in Rome, while E. coli was the main 
causative agent of BSI in the other 19 centers. I? aenrginosa isolated 
in Rome displayed a higher degree of resistance towards third-gener- 
ation cephalosporins, quinolones, gentamicin, tobramycin and 
piperacillin, while E .  coli presented higher resistance to piperacillin 
and tetracycline. 
lp8561 Surveillance of antimicrobial resistance in The 
Netherlands, 1994-98 
H. l? Endtz, A.G.M. Bniting, K.P. Verkooyen, W.C. Van Dijk, 
M.E Peeters, H.A. Verbrugh, the Mastin-Art Study Group. Medical 
Microbiology and Infectious Diseases, Erasmus Ufiiversity Medical Center, 
Rotterdam, T h e  Netherlands 
Twenty-nine laboratories participated in two collaborative surveys 
conducted in 1994-95 and in 1998. The objective of the study was 
to monitor nationwide the resistance patterns and trends in clinical 
isolates of hospitalized patients with serious infections in The 
Netherlands. The susceptibility of more than 5000 bacterial strains 
representing 15 different species was tested to 15 antimicrobial agents. 
All participating centers used the same standardized methods. MICs 
were done with Etest and NCCLS breakpoints were used. For most 
antimicrobial agents, the MICsn, a sensitive marker of changing resis- 
tance patterns, did not change significantly during the study period. 
The percentage of Enterobacteriaceae resistant to ciprofloxacin and 
trovafloxacin stabilized around 3%. However, the fluoroquinolone 
resistance in I? aenrginosa increased from 7% to 10% (ciprofloxacin) 
and 17% to 23% (trovafloxacin). The resistance rate to imipenem in 
I? aeruginosa increased from 5% to 9%. In contrast, I? aenrginosa resis- 
tant to ceftazidime and gentamicin tended to decrease. 5% (1994) and 
4% (1998) of E .  coli, and 8% (1994) and 7% (1998) of K. pneumoniae 
had ceftazidime MIC 1 mg/L, among these ESBL-producing strains 
(in study). Ciprofloxacin resistance in MSSA ranged from 2% to 4% 
(MIc911: 0.19 mg/L). AU MSSA were highly susceptible to 
trovafloxacin (MICW: 0.023 rng/L). No high-level penicillin resis- 
tance was detected in S. pneumoniae. The intermediate resistance rate 
was 2% in 1994-95 and 3% in 1998. In a worldwide environment of 
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increasing antimicrobial resistance it IS remarkable that, except in P 
aerugirrora, no significant change in resistance is readily detected in 
these two nationwide prevalence studies in The Netherlands. 
lp8571 Present situation of resistance of respiratory 
tract pathogens 
E. Cercenado, E Garcia-Garrote, K. San Juan, S. Hernangbmez, J. 
Martin-Pedroviejo, E. Bouza. Hospital Grqorio Marandn, Madrid, 
Spaiii 
Objectives: To determine the resistance of recent respiratory isolates 
(1 997-98) of S. pnelrmoniae (Sp), If. i?lpuenzae (Hi), M .  catarrlialis 
(Mc), S. pyofenes (SA) and Streptococcus group C (SC) to antimicro- 
bials and to compare resistance patterns with those of 1996 isolates. 
Materials and methods: Susceptibility to penicillin (PEN), 
ampicillin (AMP), amoxycillin-clavulanate (AMC), cefotaxime 
(CTX), erythromycin (ERY) and co-trimoxazole (SXT) was deter- 
mined by the broth microdilution method (NCCLS). Beta-lactamase 
production was detected by thmt nitrocefin test. 
Results: Percentages of resistance (NCCLS breakpoints) are 
shown in the table: 
Y m  PEN 
sp 9 6 8  2: 
Hi 96 - 
97-98 - 
Mc 96 - 
97-98 - 
SA 96 0 
~7.9~ n 
. __ 
CTX 
36 
39 
0 
0 
0 
0 
0 
n 
__ 
ERY 
32 
36 
10 
75 
__ 
AMP 
42 
46 
81 
89 
__ 
AMC 
0 
3 
2 
1 
41 
46 
47 
33 
. _I . -.
sc 96 0 0 8 - - - 
8 0 0 1 4  _ _ _  
In 1996, among non-susceptible Sp, 22% were intermediate (I) 
and 36‘31 resistant (R), whereas in 1997-98 there were 21% I and 39% 
R. MICs of CTX were 3 2  &mL against 7% of 1997-98 isolates. 
N o  resistance to CTX and to quinolones was found among Hi and 
Mc. 73% of Dryer SA isolates presented the M phenotype, whereas 
only 0.5 of EKY-R Sp presented this phenotype. 
Conclusions: Resistance to PEN, CTX and EKY continues to 
increase among Sp, as well as the incidence of beta-lactaniase-produc- 
ing Hi and ERY-R SA and SC. 
/p8581 Is there emergence of resistance to cefepime 
after 24+ months of use? 
C.H. Ramirez-Ronda, C.Raniirez-Kdmirez, D. Vera. SanJnnti 
VAMC, Department of Infectious Diseases, School of Medicine, University 
o f i i i ~ ~ r r o  Rim, SariJ~ian, Puerro Rim 
Objectives: To compare the in vitro activity ofcefepime during two 
periods, 1991-95 and 1996-98 (cefepime use period), against aero- 
bic Gram-negative bacilli recovered from serious infections in hospi- 
talized patients. 
Methods: A total of 50 strains each per year of Klebsiella pnenmo- 
niae (KP), Klebsielln oxytora (KO), Erirerobacter cloacae (EC), Citrobacter 
jienndii (FC). Psrndomorias aevtigiwosa (PA), Psendomortas maltophilia 
Pre Use 1% Susceptibility1 Post Use 
1991 1992 1993 1994 1995 1996 1997 1998 
CEF 100 100 100 100 100 100 90 100 
CTZ 56 54 52 52 52 52 54 52 
CEF 96 94 96 98 100 98 97 100 
CTZ 58 60 56 52 52 52 54 53 
Conclusions: The susceptibilities of Ktehsiriia and Entero lac~r  did 
not change over the two study perlods. The susceptibilities ofP acrq -  
inosa to cefepime remained unchanged during the first study period 
and were comparable to that of ceftazidime; during the CEF use 
period, PA susceptibility decreased by 20%). 
KP 1101981 
EC 
lp859) Resistance of ceftazidime in a Hungarian 
hospital 
11. Szabo, C. Jeney, K. Glatz, Z .  Csukas, Z. Llerek, K.  Kamotsay, F. 
Rozgonyi. Institute (f Microbiolo~qy, Semriieliveis University .f Medicine, 
Bitdupest, Huripzry 
Objectives: The resistances of strains of Esrlwririiia coli, Klcbsielln and 
Eizt~r~hacter species to a panel of third-generation cephalosporins, 
aniinoglycosides and ciprofloxacin were surveyed and the role of 
extended-spectrum beta-lactamaser (ESBLs) was studied. 
Methods: Antibiotic sensitivities of the strains were determined 
with the disk diffusion method on Mueller-Hinton agar. ESUL were 
detected by the double-disk diffusion test and Etest. Chictic detcr- 
mination of ESUL features was carried out by alkaline lysis of the 
bacterial cells, transformation and conjugation. 
Results: Out of about 600 E .  roli, 140 Klrbtielln and 450 Eritem- 
barter strains, the ratios of resistant isolates ranged 3s follows: 7-1 3% 
of E. coli, 17-40% of Klebsiella spp. and 45-52% of Entcrohacter spp. 
were resistant to third-generation cephalosporins. 5-1 1% of E .  coli, 
8-26‘3) of Klrbsiefla spp. and 8-47% of Enterobartrr cpp. showed recis- 
taiice to aminoglycosides. Further investigation of 106 ceftazidine- 
resistant or intermediate strains revealed R resistance to cefoperazone, 
ceftriaxone, gentamicin, tobrainycin and netilmicin, and a sensitivity 
to imipeneni, meropenem, ciprofloxacin and amikacin. Nine out of 
106 randomly selected ceftazidine-resistant strains proved to be ESBL 
producers. Successful transformations of plasmids from the ESRL- 
producing strains to E. roli DH5alpha resulted in resistance to 
ceftazidime, cefoperazone, ceftriaxone, tobramycin, gentamicin and 
netilmicin, while the transformed cells remained sensitive to 
carbepenerns, ciprofloxacin and amikacin. 
Conclusions: The survey has shown the simultaneous expression 
of aminoglycoside resistance and the ESLlLs. 
Resistance grampositive bacteria 
Macrolide resistance among group A 
streptococci (GAS) and S. pneumoniae (Spn) in 
Belgium 
(PM) and Srrratia nzarcrsrerts (SE) were collected and simultaneously 
tested in duplicate using the diisk diffusion test with NCCLS stan- 
dards. The years were 1991-98, and a total of 2750 strains were 
tested. 
P. Detcheemaeker, S. Chapelle, M. Hauchecorile, M. WiJdooghe, 
P. Vandamme, G. leven, H. Goossens. L’rzivcrrity ofilntwcrp, 
Aritwc’rp, Be[qiirm 
Results: The susceptibility of KP, K O  and EC remained similar 
from 1991 to 1998. For KP and K O  the most active agents were CEF 
and imipenem, and for EC the sanie was true. For PA, CEF and C T Z  
there was a gradual loss of susceptibility over the last 3 years 
(1995-98) to both agents. 
Resistance of GAS and Spn to iiiacrolides is caused by drug efflux 
and target site modification (MLSU phenotype) which can be 
inducible (I-MLSB) or constitutive (C-MLSB). 
One hundred and thirty-one (6.5%) erythromycin-resistant (ERY- 
R) strains (MIC? 1 pg/mL), detected miong 2014 Belgian GAS 
